AngioSoma, Inc. (SOAN) financial statements (2021 and earlier)

Company profile

Business Address 2500 WILCREST DRIVE, 3RD FLOOR
HOUSTON, TX 77042
State of Incorp. NV
Fiscal Year End September 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
TTM
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments491009214661
Cash and cash equivalents491009214661
Receivables     516
Inventory, net of allowances, customer advances and progress billings40404    
Inventory40404    
Prepaid expense31 11112
Deferred costs(3)      
Other undisclosed current assets3 16    
Total current assets:921411121571129
Noncurrent Assets
Property, plant and equipment111    
Oil and gas property, full cost method     255396
Long-term investments and receivables   10115652
Long-term investments   10115652
Other undisclosed noncurrent assets  12    
Total noncurrent assets:11131011311448
TOTAL ASSETS:931421252517322478
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:133135137137165131246
Interest and dividends payable22822823214763354
Other undisclosed accounts payable and accrued liabilities(94)(93)(95)(10)10296242
Debt1751731002015066296
Asset retirement obligation     1515
Due to related parties1133516014128  
Other undisclosed current liabilities289168699207389354
Total current liabilities:710828995505732247561
Noncurrent Liabilities
Long-term debt and lease obligation   6969449
Long-term debt, excluding current maturities   6969449
Liabilities, other than long-term debt   75341913
Accounts payable and accrued liabilities   7534137
Asset retirement obligations     66
Other undisclosed noncurrent liabilities    26  
Total noncurrent liabilities:   1441286321
Total liabilities:710828995649860310582
Stockholders' equity
Stockholders' equity attributable to parent, including:(617)(685)(871)(624)(843)13(104)
Preferred stock     1 
Common stock21017069463493
Additional paid in capital6,0061,2252,0651,521(366)4,4243,232
Accumulated other comprehensive income (loss)  1(1) 2117
Accumulated deficit(6,835)(6,674)(5,999)(5,182)(3,502)(4,442)(3,357)
Other undisclosed stockholders' equity attributable to parent24,5922,9922,9932,992  
Total stockholders' equity:(617)(685)(871)(624)(843)13(104)
TOTAL LIABILITIES AND EQUITY:931421252517322478

Income statement (P&L) ($ in thousands)

12/31/2019
TTM
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
Revenues00110 4297
Revenue, net  42 
Realized investment gains   10   
Cost of revenue
(Cost of Goods and Services Sold)
(0)(0)(0)  (18)(20)
Gross profit:00110 2577
Operating expenses(261)(316)(352)(461) (740)(52)
Other undisclosed operating income (loss)   (10) 18(483)
Operating loss:(261)(316)(351)(461) (698)(458)
Nonoperating income (expense)232 611 453(788)
Investment income, nonoperating   11   
Debt instrument, convertible, beneficial conversion feature     453 
Other nonoperating income (expense)(87) 6    
Interest and debt expense(423)(349)(464)(1,229) (388)(788)
Other undisclosed income from continuing operations before equity method investments, income taxes     5022,078
Net income (loss):(452)(664)(809)(1,680) (131)45
Other undisclosed net loss attributable to parent(55)(11)(7)  (954)(1,290)
Net loss attributable to parent:(508)(675)(817)(1,680) (1,086)(1,245)
Preferred stock dividends and other adjustments (1,600)     
Other undisclosed net loss available to common stockholders, basic(1,600)      
Net loss available to common stockholders, diluted:(2,108)(2,275)(817)(1,680) (1,086)(1,245)

Comprehensive Income ($ in thousands)

12/31/2019
TTM
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
Net income (loss):(452)(664)(809)(1,680) (131)45
Other comprehensive loss   (1)   
Comprehensive income (loss):(452)(664)(809)(1,681) (131)45
Other undisclosed comprehensive loss, net of tax, attributable to parent(143)(12)(5)  (950)(1,273)
Comprehensive loss, net of tax, attributable to parent:(596)(676)(815)(1,681) (1,082)(1,228)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: